Dr Reddys Laboratories (RDY) EBITDA (2009 - 2026)
Dr Reddys Laboratories' EBITDA came in at $187.82 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 27.4% from $258.69 million a year earlier but up 94.2% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Dr Reddys Laboratories reported EBITDA of $529.04 million, down 48.7% year-over-year; for FY2026 (ended Mar 31, 2026), it was $806.19 million, down 22.6% from FY2025.
- EBITDA carries a five-year compound annual growth rate of 9.7% (FY2021 to FY2026).
- Going back by fiscal year, EBITDA was $1.04 billion in FY2025 (+5.1%), $991 million in FY2024 (+16.7%), $849 million in FY2023 (+55.8%) and $545 million in FY2022 (+7.5%).
- The five-year range for quarterly EBITDA is $49.34 million (fiscal Q4 2026) to $277.55 million (fiscal Q3 2025).
- Year-over-year, EBITDA has declined for four consecutive quarters, with an average decline of 23.0% over the last eight quarters.
- The fastest year-over-year change in EBITDA over five years came in fiscal Q4 2023 (growth of 321.2%), and the weakest in fiscal Q4 2026 (a decline of 78.9%).
- Business Quant data shows RDY's EBITDA at $96.71 million (Q1 2027), $49.34 million (Q4 2026) and $195.18 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 187.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 187.82 Mn |
| Jun 30, 2026 | 96.71 Mn |
| Mar 31, 2026 | 49.34 Mn |
| Dec 31, 2025 | 195.18 Mn |
| Sep 30, 2025 | 258.69 Mn |
| Jun 30, 2025 | 259.87 Mn |
| Mar 31, 2025 | 234.33 Mn |
| Dec 31, 2024 | 277.55 Mn |
| Sep 30, 2024 | 257.01 Mn |
| Jun 30, 2024 | 260.55 Mn |
| Mar 31, 2024 | 224.84 Mn |
| Dec 31, 2023 | 252.65 Mn |
| Sep 30, 2023 | 261.97 Mn |
| Jun 30, 2023 | 258.44 Mn |
| Mar 31, 2023 | 250.79 Mn |
| Dec 31, 2022 | 190.84 Mn |
| Sep 30, 2022 | 239.21 Mn |
| Jun 30, 2022 | 234.55 Mn |
| Mar 31, 2022 | 59.54 Mn |
| Dec 31, 2021 | 114.72 Mn |
API Access
Dr Reddys Laboratories EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();